Breathing New Life: Stem Cell Therapy’s Breakthrough in Treating Interstitial Lung Disease
James W. Watson2025-05-26T23:19:30+08:00Discover how genetically modified mesenchymal stem cells (iMSC/NCR101) combat interstitial lung disease (ILD) through Phase I trials in Hefei. Explore mechanisms, safety data, and regenerative potential of this breakthrough therapy for pulmonary fibrosis.











